Description: Non Mineral oil based injectable vaccine containing two strains of Aeromonas salmonicida and protein antigens cloned from VP2 and VP3 of the IPN Virus produced in a yeast expression system.

Target Species: Atlantic salmon

Key Benefits:

• High levels of protection against IPN in smolts in sea water.
• Patented Iron Regulated Outer Membrane protein (IROMPs) antigens.
• Broad spectrum protection against furunculosis including atypical strains found in Chile.
• The relative safety of the adjuvant system allows the vaccine to be used early in the production cycle maximizing the protective effect against IPN.
• Compatible with AquaVac IPN oral vaccine used in the hatchery.
• This system has been proven to minimize the side-effects of using oil-base injectable vaccines while maintaining the high levels of protection.
• Long lasting protection conferred by the depot effect of the adjuvant system.

Label Indications: This product is recommended for the reduction in mortality due to furunculosis and IPN disease caused by Aeromonas salmonicida and IPN virus in healthy Atlantic salmon.

Dosage and Administration:

Injection - Vaccination Method:
The vaccine is recommended for fish of 25g and larger. The fish should be anaesthetized prior to vaccination with an anesthetic approved for use in fish.

Withdrawal time: Zero days**
**Approved species, claims and withdrawal times may vary from country to country. Please check your local package insert or contact your local Schering-Plough Animal Health representative for more details.

Product Presentation: AquaVac* FNM^PLUSIPN is available in 500ml high-density polyethylene flat bottles.

Storage Conditions: Store at 2^oC to 8^oC. Do not freeze. Protect from light. Use entire contents after 5 hours when first opened.

Precautions: Minimum fish size for injection: 25g. Avoid self-injection.

Target Diseases:

• Furunculosis
• IPN

* Trademark